FDA Plans eMDR System Updates

The U.S. Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH) plans to update the FDA’s electronic medical device reporting (eMDR) system to reflect updates to the FDA Form 3500A and other system enhancements. The FDA Form 3500A is...

FDA Clears GE Healthcare’s Deep Learning-Based MR Image Reconstruction

GE Healthcare has announced U.S. FDA 510(k) clearance of AIR Recon DL. “This pioneering technology, using a deep learning-based neural network, improves the patient experience through shorter scan times while also increasing diagnostic confidence with better image...

GlobalData: Impact of COVID-19 on diagnostic imaging not as severe compared to other areas

The impact of COVID-19 on diagnostic imaging (DI) procedures will not be as severe compared to other therapy areas, such as aesthetics and dental, since only 38.7% of these procedures are elective and expected to drop due to the COVID-19 pandemic, according to...

FDA Approves Cerianna

PETNET Solutions Inc., a Siemens Healthineers company, and Zionexa USA, a wholly owned subsidiary of Zionexa SAS, have announced that the Food and Drug Administration (FDA) has approved Cerianna (fluoroestradiol F 18) injection for intravenous use. Cerianna...

Acertara Adds Johns Hopkins Physicist to Team

Acertara, an independent ISO/IEC 17025:2005 accredited medical ultrasound acoustic measurement, testing, and calibration laboratory, and ISO 13485:2003 certified probe repair and new product development facility has announced the addition of Nicholas Ellens, Ph.D. to the Acertara team. Ellens will oversee the expanding acoustic power testing lab and will expand upon the capabilities of Acertara’s research and development team.

“I’m excited to join such a highly-accomplished team like Acertara and for the opportunity to grow the acoustic power measurement laboratory the same way the company continues to strengthen its reputation – through a steadfast dedication to providing the health care market with best-in-class services and advanced technological solutions,” said Ellens.

Ellens joins Acertara directly from the Johns Hopkins University Department of Radiology–Division of MR Research faculty. His research at Johns Hopkins University included projects such as focused ultrasound used to deliver medications across the blood-brain-barrier, and MR-guided high intensity focused ultrasound (HIFU).

Ellens earned his Ph.D. from the University of Toronto where his thesis was on electronically steered phased arrays for focused ultrasound surgery applications. Prior research includes work conducted at various institutions including Sunnybrook Research Institute, Harvard University and the Department of National Defense. Additionally, Ellens is a widely published author on focused ultrasound.

“We continue to add to our world-class team at Acertara and I am absolutely thrilled to welcome Nick to our team,” said G. Wayne Moore, president and CEO of Acertara. “The addition of Nick further underscores Acertara as the premier supplier of acoustic testing services and products.”



Submit a Comment

Your email address will not be published. Required fields are marked *